Literature DB >> 12401610

The effects of general anesthetics on norepinephrine release from isolated rat cortical nerve terminals.

Victor N Pashkov1, Hugh C Hemmings.   

Abstract

UNLABELLED: Intravenous and volatile general anesthetics inhibit norepinephrine (NE) release from sympathetic neurons and other neurosecretory cells. However, the actions of general anesthetics on NE release from central nervous system (CNS) neurons are unclear. We investigated the effects of representative IV and volatile anesthetics on [(3)H]NE release from isolated rat cortical nerve terminals (synaptosomes). Purified synaptosomes prepared from rat cerebral cortex were preloaded with [(3)H]NE and superfused with buffer containing pargyline (a monoamine oxidase inhibitor) and ascorbic acid (an antioxidant). Basal (spontaneous) and stimulus-evoked [(3)H]NE release was evaluated in the superfusate in the absence or presence of various anesthetics. Depolarization with increased concentrations of KCl (15-20 mM) or 4-aminopyridine (0.5-1.0 mM) evoked concentration- and Ca(2+)-dependent increases in [(3)H]NE release from rat cortical synaptosomes. The IV anesthetics etomidate (5-40 microM), ketamine (5-30 microM), or pentobarbital (25-100 microM) did not affect basal or stimulus-evoked [(3)H]NE release. Propofol (5-40 microM) increased basal [(3)H]NE release and, at larger concentrations, reduced stimulus-evoked release. The volatile anesthetic halothane (0.15-0.70 mM) increased basal [(3)H]NE release, but did not affect stimulus-evoked release. These findings demonstrate drug-specific stimulation of basal NE release. Noradrenergic transmission may represent a presynaptic target for selected general anesthetics in the CNS. Given the contrasting effects of general anesthetics on the release of other CNS transmitters, the presynaptic actions of general anesthetics are both drug- and transmitter-specific. IMPLICATIONS: General anesthetics affect synaptic transmission both by altering neurotransmitter release and by modulating postsynaptic responses to transmitter. Anesthetics exert both drug-specific and transmitter-specific effects on transmitter release: therapeutic concentrations of some anesthetics stimulate basal, but not evoked, norepinephrine release, in contrast to evoked glutamate release, which is inhibited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401610     DOI: 10.1097/00000539-200211000-00032

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Effect of intravenous anesthetic propofol on synaptic vesicle exocytosis at the frog neuromuscular junction.

Authors:  Luciana Ferreira Leite; Renato Santiago Gomez; Matheus de Castro Fonseca; Marcus Vinicius Gomez; Cristina Guatimosim
Journal:  Acta Pharmacol Sin       Date:  2010-11-29       Impact factor: 6.150

2.  Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.

Authors:  Nadia Ayala-Lopez; William F Jackson; Robert Burnett; James N Wilson; Janice M Thompson; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-02       Impact factor: 4.733

3.  Regional differences in the effects of isoflurane on neurotransmitter release.

Authors:  Robert I Westphalen; No-Bong Kwak; Keir Daniels; Hugh C Hemmings
Journal:  Neuropharmacology       Date:  2011-05-30       Impact factor: 5.250

4.  Nicotinic receptor-evoked hippocampal norepinephrine release is highly sensitive to inhibition by isoflurane.

Authors:  R I Westphalen; R S Gomez; H C Hemmings
Journal:  Br J Anaesth       Date:  2009-02-02       Impact factor: 9.166

Review 5.  The Effects of General Anesthetics on Synaptic Transmission.

Authors:  Xuechao Hao; Mengchan Ou; Donghang Zhang; Wenling Zhao; Yaoxin Yang; Jin Liu; Hui Yang; Tao Zhu; Yu Li; Cheng Zhou
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

6.  Connection changes in somatosensory cortex induced by different doses of propofol.

Authors:  Zhaoduan Li; Xingkui Liu; Yi Zhang; Jinshan Shi; Yu Zhang; Peng Xie; Tian Yu
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.